AngioDynamics PT Raised to $13.00 at Canaccord Genuity (ANGO)
Research analysts at Canaccord Genuity hoisted their target price on shares of AngioDynamics (NASDAQ:ANGO) from $11.50 to $13.00 in a report released on Friday, Stock Ratings Network.com reports. The firm currently has a “hold” rating on the stock. Canaccord Genuity’s price target suggests a potential downside of 10.16% from the stock’s previous close.
A number of other analysts have also recently weighed in on ANGO. Analysts at Zacks reiterated a “neutral” rating on shares of AngioDynamics in a research note to investors on Tuesday, October 1st. They now have a $14.00 price target on the stock.
Shares of AngioDynamics (NASDAQ:ANGO) traded up 1.33% during mid-day trading on Friday, hitting $14.47. The stock had a trading volume of 564,042 shares. AngioDynamics has a one year low of $9.52 and a one year high of $14.44. The stock has a 50-day moving average of $12.1 and a 200-day moving average of $11.36. The company’s market cap is $505.3 million.
AngioDynamics (NASDAQ:ANGO) last announced its earnings results on Thursday, October 10th. The company reported $0.04 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.03 by $0.01. The company had revenue of $83.60 million for the quarter, compared to the consensus estimate of $82.54 million. During the same quarter last year, the company posted $0.10 earnings per share. AngioDynamics’s revenue was up .2% compared to the same quarter last year. Analysts expect that AngioDynamics will post $0.32 EPS for the current fiscal year.
AngioDynamics, Inc designs manufacture and sell a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.